Indivior to release generic version of opioid drug after losing court battle
By Frank Prenesti
Date: Wednesday 20 Feb 2019
(Sharecast News) - Indivior said it was releasing an authorised generic version of its Suboxone opiod addiction treatment in the US after losing a court bid to stop a copycat version made by India-based rival Dr. Reddy's Laboratories.
The US Supreme Court on Tuesday cleared the way for a cut-price version of Indivior's Suboxone Film.
Chief executive Shaun Thaxter said the company was making an the generic drug available to patients and providers immediately, "giving them yet another option of medication-assisted treatment for opioid dependence".
"In addition, we expect this launch will create the opportunity to maximize the value of our Suboxone Film franchise," he said.
"With the launch of this authorized generic by Indivior, it is possible that other companies may also launch their own generic versions of Suboxone Film."
The company's authorized generic is being marketed and distributed by Sandoz.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN